Jasper Therapeutics, Inc. (JSPRW) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: February 25, 2025
Jasper Therapeutics, Inc. (JSPRW) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Jasper Therapeutics, Inc. (Stock Symbol: JSPRW)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $3 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Jasper Therapeutics, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Jasper Therapeutics, Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Jasper Therapeutics, Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Jasper Therapeutics, Inc. interactive price chart and technical analysis...
Deep dive into Jasper Therapeutics, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Jasper Therapeutics, Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Jasper Therapeutics, Inc.:
P/B Ratio0.04x
Market Cap$3M
EPS$-1.24
Book Value/Share$5.58
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Jasper Therapeutics, Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Jasper Therapeutics, Inc.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Jasper Therapeutics, Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Jasper Therapeutics, Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Jasper Therapeutics, Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Jasper Therapeutics, Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Jasper Therapeutics, Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Jasper Therapeutics, Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Jasper Therapeutics, Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Jasper Therapeutics, Inc.:
Income Statement ($ Millions)
Operating Income$-19M
Net Income$-18M
R&D Expense$14M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding15M
Growth Metrics (YoY)
EPS Growth-844.1%
Jasper Therapeutics, Inc. (JSPRW) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Jasper Therapeutics, Inc. stock analysis.
Loading fundamental data...
Loading Jasper Therapeutics, Inc. comprehensive fundamental analysis and insider trading data...
Latest Jasper Therapeutics, Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Jasper Therapeutics, Inc. (JSPRW) stock price and investment outlook.
REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ...
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been given an average recommendation of “Buy” by the nine brokerages that are presently covering the company, Marketbeat Ratings ...
Shares of Jasper Therapeutics, Inc. Have increased 384.45% over the past quarter, and have gained 41% in the last year. In comparison, the S&P 500 has only moved 10.08% and 35.76%, respectively.
Following the closing, the combined company will operate as Jasper Therapeutics, Inc. and, on or about September 27, 2021, its shares of voting common stock and warrants are expected to begin ...
Each Option was granted pursuant to the Jasper Therapeutics, Inc. Amended and Restated 2022 Inducement Equity Incentive Plan, as approved by the compensation committee of Jasper’s board of ...
Jasper Therapeutics, Inc. Announces Reverse Stock Split PRESS RELEASE GlobeNewswire Jan. 2, 2024, 08:00 AM ...
Jasper Therapeutics, Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Jasper Therapeutics, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Jasper Therapeutics, Inc. Stock Forecast
How accurate are Jasper Therapeutics, Inc. stock predictions?
Our AI model demonstrates 8500% historical accuracy for JSPRW predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Jasper Therapeutics, Inc. stock price forecasts?
Is Jasper Therapeutics, Inc. a good investment in 2025?
Based on our AI analysis, Jasper Therapeutics, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Jasper Therapeutics, Inc. forecasts updated?
Jasper Therapeutics, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Jasper Therapeutics, Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Jasper Therapeutics, Inc. stock.
